ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

UCLA Forms Environmental Genomics Program

March 14, 2003

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

July 22, 1988

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

June 16, 1995

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005